Coleman Mark

DirectorAxsome Therapeutics, Inc. (AXSM) · full profile →Form 4 · filed Jun 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$4.0M
Net Open-Market Flow
-$4.0M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 2, 2026Sell(S)6K$223.39$1.2M30K
Jun 1, 2026Sell(S)6K$230.30$1.4M35K
May 29, 2026Sell(S)6K$233.46$1.4M41K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-254038) within minutes of acceptance. Every field above traces to the original document. Verify it directly: